source
- Healthcare giants increasingly develop in-house AI tools instead of buying from startupsPanelists at the Digital Healthcare Innovation Summit in Boston highlighted a growing shift among large health‑care organizations toward creating their own artificial‑intelligence solutions. Rather…
- JAK inhibitor sequencing and transplant timing in myelofibrosis discussed at 2026 conferenceDr. Andrew Kuykendall of Moffitt Cancer Center explained how doctors decide the order of JAK inhibitor therapies and when to consider allogeneic stem cell transplant for myelofibrosis patients. At…